ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Machine learning-based screening of an epithelial-mesenchymal transition-related long non-coding RNA signature reveals lower-grade glioma prognosis and the tumor microenvironment and predicts antitumor therapy response

Wang, Nan; Gao, Xin; Ji, Hang; Ma, Shuai; Wu, Jiasheng; Dong, Jiawei; Wang, Fang; Zhao, Hongtao; Liu, Zhihui; Yan, Xiuwei; Li, Bo; Du, Jianyang*; Zhang, Jiheng*; Hu, Shaoshan*哈尔滨医科大学; 四川大学
Frontiers in Molecular Biosciences2022-8-26DOI: 10.3389/fmolb.2022.942966
5阅读
引用收藏
分享

摘要

Epithelial-mesenchymal transition (EMT) confers high invasive and migratory capacity to cancer cells, which limits the effectiveness of tumor therapy. Long non-coding RNAs (lncRNAs) can regulate the dynamic process of EMT at different levels through various complex regulatory networks. We aimed to comprehensively analyze and screen EMT-related lncRNAs to characterize lower-grade glioma (LGG) tumor biology and provide new ideas for current therapeutic approaches. We retrieved 1065 LGG samples from the Cancer Genome Atlas and Chinese Glioma Genome Atlas by machine learning algorithms, identified three hub lncRNAs including CRNDE, LINC00665, and NEAT1, and established an EMT-related lncRNA signature (EMTrLS). This novel signature had strong prognostic value and potential clinical significance. EMTrLS described LGG genomic alterations and clinical features including gene mutations, tumor mutational burden, World Health Organization (WHO) grade, IDH status, and 1p/19q status. Notably, stratified analysis revealed activation of malignancy-related and metabolic pathways in the EMTrLS-high cohort. Moreover, the population with increased EMTrLS scores had increased cells with immune killing function. However, this antitumor immune function may be suppressed by increased Tregs and macrophages. Meanwhile, the relatively high expression of immune checkpoints explained the immunosuppressive state of patients with high EMTrLS scores. Importantly, we validated this result by quantifying the course of antitumor immunity. In particular, EMTrLS stratification enabled assessment of the responsiveness of LGG to chemotherapeutic drug efficacy and PD1 blockade. In conclusion, our findings complement the foundation of molecular studies of LGG, provide valuable insight into our understanding of EMT-related lncRNAs, and offer new strategies for LGG therapy.

学科与关键词

关键词
epithelial-mesenchymal transitionlong non-coding RNAslower-grade gliomastumor microenvironmentantitumor treatment
相关
加载中…
  • Identification of EMT-Related Genes and Prognostic Signature With Significant Implications on Biological Properties and Oncology Treatment of Lower Grade Gliomas
    Wu, Jiasheng; He, Jinru; Zhang, Jiheng; Ji, Hang; Wang, Nan; Ma, Shuai; Yan, Xiuwei; Gao, Xin; Du, Jianyang*; Liu, Zhihui*; Hu, Shaoshan*Frontiers in Cell and Developmental Biology, 2022, 10: 887693.被引 1
  • Machine learning-based identification of tumor-infiltrating immune cell-associated lncRNAs for improving outcomes and immunotherapy responses in patients with low-grade glioma
    Zhang, Nan; Zhang, Hao; Wu, Wantao; Zhou, Ran; Li, Shuyu; Wang, Zeyu; Dai, Ziyu; Zhang, Liyang; Liu, Fangkun; Liu, Zaoqu; Zhang, Jian; Luo, Peng; Liu, Zhixiong*; Cheng, Quan*2022, 12(13): 5931-5948.被引 49
  • 5-Methylcytosine Related LncRNAs Reveal Immune Characteristics, Predict Prognosis and Oncology Treatment Outcome in Lower-Grade Gliomas
    Zhang, Jiheng; Wang, Nan; Wu, Jiasheng; Gao, Xin; Zhao, Hongtao; Liu, Zhihui; Yan, Xiuwei; Dong, Jiawei; Wang, Fang; Ba, Yixu; Ma, Shuai; Jin, Jiaqi; Du, Jianyang; Ji, Hang*; Hu, Shaoshan*Frontiers in Immunology, 2022, 13: 844778.被引 15
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Molecular Biosciences
发表日期
2022-08-26
卷期
第 9 卷
页码
942966
DOI
10.3389/fmolb.2022.942966
期刊等级
3区
成果收录
SCIE
资助标注
Zhejiang Provincial People's Hospital Talent Introduction Project; [C-2021-QDJJ03-01]

作者

  • W

    Wang, Nan (第一作者)

    zhejiang prov peoples hosp · 2 · harbin med univ

  • G

    Gao, Xin

    2 · harbin med univ

查看全部 14 位作者收起作者
  • J

    Ji, Hang

    sichuan univ

  • M

    Ma, Shuai

    zhejiang prov peoples hosp

  • W

    Wu, Jiasheng

    2 · harbin med univ

  • D

    Dong, Jiawei

    zhejiang prov peoples hosp

  • W

    Wang, Fang

    zhejiang prov peoples hosp

  • Z

    Zhao, Hongtao

    zhejiang prov peoples hosp

  • L

    Liu, Zhihui

    zhejiang prov peoples hosp

  • Y

    Yan, Xiuwei

    zhejiang prov peoples hosp

  • L

    Li, Bo

  • D

    Du, Jianyang (通讯)

    shandong prov hosp

  • Z

    Zhang, Jiheng (通讯)

    zhejiang prov peoples hosp · 2 · harbin med univ

  • H

    Hu, Shaoshan (通讯)

    zhejiang prov peoples hosp · 2 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417